“Repurposing” of Xanthine Oxidoreductase as a Nitrite Reductase: A New Paradigm for Therapeutic Targeting in Hypertension
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
SIGNIFICANCE: In contrast to nitric oxide (NO), which has well-established, important effects in regulation of cardiovascular homeostasis, its oxidative metabolite nitrite has, until recently, been considered to be of minor functional significance. RECENT ADVANCES: However, this view of nitrite has been radically revised over the past 10 years with evidence now supporting a critical role for this anion as a storage form of NO. CRITICAL ISSUES: Importantly, while hypoxia and acidosis have been shown to play a pivotal role in the generation of nitrite to NO, a number of mammalian nitrite reductases have been identified that facilitate the reduction of nitrite. Critically, these nitrite reductases have been demonstrated to operate under physiological pH conditions and in normoxia, extending the functional remit of this anion from an ischemic mediator to an important regulator of physiology. One particular nitrite reductase that has been shown to operate under a wide range of environmental conditions is the enzyme xanthine oxidoreductase (XOR). FUTURE DIRECTIONS: In this review, we discuss the evidence supporting a role for XOR as a nitrite reductase while focusing particularly on its function in hypertension. In addition, we discuss the potential merit in exploiting this activity of XOR in the therapeutics of hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · cited 1×
“…has been that nitrite reduction is a phenomenon that increases with decreasing pH and oxygen tension, conditions that simultaneously upregulate and favor the activity of a number of distinct vascular nitrite reductases, including XOR, deox-yhemoglobin, AO, and even endothelial NO synthase (76).”
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807 · cited 3×
“Indeed, in 2003, Gladwin and co-workers demonstrated that near-physiological concentrations of nitrite infused into the brachial artery of healthy volunteers produced significant increases in forearm blood flow (14).”
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
Inorganic nitrate is a possible source for systemic generation of nitric oxide
Lundberg, J. O., & Govoni, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.027 · Cited by 657 · cited 3×
“This nitrate is then secreted into the oral cavity in the saliva (116, 126), resulting in salivary concentrations * 10 times that in plasma (75, 116, 137).”
Inorganic Nitrate Supplementation Lowers Blood Pressure in Humans: Role for Nitrite-Derived NO
Kapil, V., Milsom, A. B., Okorie, M., Maleki-Toyserkani, S., Akram, F., Rehman, F., Arghandawi, S., Pearl, V., Benjamin, N., Loukogeorgakis, S., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.153536 · Cited by 621 · cited 2×
“It is this sustained elevation of nitrite that is thought to underlie the impressive effects of inorganic nitrate on BP in healthy volunteers (60, 70, 137).”
Self-citationWebb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N., & Ahluwalia, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402927101 · Cited by 608 · cited 3×
“In addition, we have demonstrated significant nitrite reductase activity that is abolished in the presence of allopurinol in human atrial tissue, implicating XOR (135).”
InfluentialSelf-citationSpiegelhalder, B., Eisenbrand, G., & Preussmann, R. (1976) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(76)80005-3 · Cited by 596
Effects of Dietary Nitrate on Blood Pressure in Healthy Volunteers
Larsen, F. J., Ekblom, B., Sahlin, K., Lundberg, J. O., & Weitzberg, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmc062800 · Cited by 587 · cited 1×
“It is this sustained elevation of nitrite that is thought to underlie the impressive effects of inorganic nitrate on BP in healthy volunteers (60, 70, 137).”
Millar, T. M., Stevens, C. R., Benjamin, N., Eisenthal, R., Harrison, R., & Blake, D. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00430-x · Cited by 491
An Extremely Potent Inhibitor of Xanthine Oxidoreductase
Okamoto, K., Eger, B. T., Nishino, T., Kondo, S., Pai, E. F., & Nishino, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208307200 · Cited by 434
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase
Godber, B. L. J., Doel, J. J., Sapkota, G. P., Blake, D. R., Stevens, C. R., Eisenthal, R., & Harrison, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7757 · Cited by 411 · cited 1×
“Under anaerobic conditions and in the presence of either NADH or xanthine, purified XOR can also catalyze the reduction of nitrite to NO (34, 71).”
The effect of nitrate intake on nitrite formation in human saliva
Tannenbaum, S. R., Weisman, M., & Fett, D. (1976) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(76)80006-5 · Cited by 381 · cited 2×
“This nitrate is then secreted into the oral cavity in the saliva (116, 126), resulting in salivary concentrations * 10 times that in plasma (75, 116, 137).”
White, C. R., Darley-Usmar, V, Berrington, W. R., McAdams, M., Gore, J. Z., Thompson, J. A., Parks, D. A., Tarpey, M. M., & Freeman, B. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8745 · Cited by 367
Non-Enzymatic Nitric Oxide Synthesis in Biological Systems
Zweier, J. L., Samouilov, A., & Kuppusamy, P. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00018-3 · Cited by 363
Evaluation of bacterial nitrate reduction in the human oral cavity
Doel, J. J., Benjamin, N., Hector, M. P., Rogers, M., & Allaker, R. P. (2005) · European Journal of Oral Sciences · doi:10.1111/j.1600-0722.2004.00184.x · Cited by 362
Dejam, A., Hunter, C. J., Tremonti, C., Pluta, R. M., Hon, Y. Y., Grimes, G., Partovi, K., Pelletier, M. M., Oldfield, E. H., Cannon, R. O., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.712133 · Cited by 334
The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans
Pannala, A. S., Mani, A. R., Spencer, J. P. E., Skinner, V., Bruckdorfer, K. R., Moore, K. P., & Rice-Evans, C. A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01353-9 · Cited by 287
Characterization of the Magnitude and Kinetics of Xanthine Oxidase-catalyzed Nitrite Reduction
Li, H., Samouilov, A., Liu, X., & Zweier, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011648200 · Cited by 280 · cited 4×
“Further extensive analysis of the nitrite reductase activity of bovine XOR was conducted by Jay Zweier and his group (71, 73).”
InfluentialCoronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease
Guzik, T. J., Sadowski, J., Guzik, B., Jopek, A., Kapelak, B., Przybyłowski, P., Wierzbicki, K., Korbut, R., Harrison, D. G., & Channon, K. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000196651.64776.51 · Cited by 278
Carlström, M., Persson, A. E. G., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., Weitzberg, E., & Lundberg, J. O. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq366 · Cited by 261 · cited 1×
“Importantly, chronic oral administration of nitrite reduces BP without any evidence of tachyphylaxis in genetic, surgical, and salt-induced animal models of hypertension (8, 12, 13, 41, 88), although in general the doses of nitrite tested in these studies substantially exceed physiological levels.”
Zhang, Z., Naughton, D., Winyard, P. G., Benjamin, N., Blake, D. R., & Symons, M. C. R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9226 · Cited by 246 · cited 3×
“The process of nitrite reduction was first described to occur under hypoxic conditions and functioning optimally in the presence of NADH as the reducing substrate (85, 140).”
Petersson, J., Carlström, M., Schreiber, O., Phillipson, M., Christoffersson, G., Jägare, A., Roos, S., Jansson, E. Å., Persson, A. E. G., Lundberg, J. O., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.011 · Cited by 235 · cited 1×
“Vasodilator and Hypotensive Effects of Nitrite Systemic nitrite administration causes dose-dependent increases in blood flow and accordingly decreases in BP in both healthy animals and volunteers (14, 15, 102, 132).”
Ghosh, S. M., Kapil, V., Fuentes-Calvo, I., Bubb, K. J., Pearl, V., Milsom, A. B., Khambata, R., Maleki-Toyserkani, S., Yousuf, M., Benjamin, N., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00933 · Cited by 218 · cited 1×
“Crucially, at this dose, nitrite had minimal effects on BP in the normotensive Wistar Kyoto (WKY) control (33).”
Self-citationSialin ( SLC17A5 ) functions as a nitrate transporter in the plasma membrane
Qin, L., Liu, X., Sun, Q., Fan, Z., Xia, D., Ding, G., Ong, H. L., Adams, D., Gahl, W. A., Zheng, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116633109 · Cited by 216 · cited 1×
“While much of the nitrate is excreted by the kidneys 25% undergoes uptake from the circulation by the salivary glands (42, 52, 126) via a sialic acid transporter, sialin (a 2NO 3 - /H + co-trans-porter) (105).”
Aamand, R., Dalsgaard, T., Jensen, F. B., Simonsen, U., Roepstorff, A., & Fago, A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00525.2009 · Cited by 213 · cited 2×
“More recently, there has been some suggestion that carbonic anhydrase may also play a role (1, 96) (Fig.”
Hypoxic Modulation of Exogenous Nitrite-Induced Vasodilation in Humans
Maher, A. R., Milsom, A. B., Gunaruwan, P., Abozguia, K., Ahmed, I., Weaver, R. A., Thomas, P., Ashrafian, H., Born, G. V. R., James, P. E., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.719591 · Cited by 210
Landmesser, U., Spiekermann, S., Preuss, C., Sorrentino, S., Fischer, D., Manes, C., Mueller, M., & Drexler, H. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258415.32883.bf · Cited by 210
Webb, A. J., Milsom, A. B., Rathod, K. S., Chu, W. L., Qureshi, S., Lovell, M. J., Lecomte, F. M. J., Perrett, D., Raimondo, C., Khoshbin, E., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.175810 · Cited by 203 · cited 3×
“…recently, we have demonstrated that this binding is not only occurring at the level of the endothelial cell but also likely occurring at the level of the red blood cell, since immunohistochemical studies demonstrate large amounts of XOR on the membrane of erythrocytes from healthy volunteers (136).”
Self-citationLi, H., Samouilov, A., Liu, X., & Zweier, J. L. (2003) · Biochemistry · doi:10.1021/bi026385a · Cited by 180
Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta‐Analysis
Agarwal, V., Hans, N., & Messerli, F. H. (2013) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00701.x · Cited by 173 · cited 1×
“A recent meta-analysis determined that allopurinol administration on average results in a 3.3 and 1.9 mmHg reduction in systolic BP (SPB) and diastolic BP (DPB), respectively (5).”
InfluentialThe oral bioavailability of nitrate from nitrate-rich vegetables in humans
van Velzen, A. G., Sips, A. J. A. M., Schothorst, R. C., Lambers, A. C., & Meulenbelt, J. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.07.019 · Cited by 172 · cited 1×
“Orally ingested nitrate is rapidly absorbed across the upper gastrointestinal tract and by-passes first-pass metabolism with close to 100% bioavailability (130).”
Montenegro, M. F., Amaral, J. H., Pinheiro, L. C., Sakamoto, E. K., Ferreira, G. C., Reis, R. I., Marçal, D. M. O., Pereira, R. P., & Tanus-Santos, J. E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.005 · Cited by 152 · cited 1×
“Importantly, chronic oral administration of nitrite reduces BP without any evidence of tachyphylaxis in genetic, surgical, and salt-induced animal models of hypertension (8, 12, 13, 41, 88), although in general the doses of nitrite tested in these studies substantially exceed physiological levels.”
Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation
Li, H., Samouilov, A., Liu, X., & Zweier, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314336200 · Cited by 146 · cited 2×
“Further extensive analysis of the nitrite reductase activity of bovine XOR was conducted by Jay Zweier and his group (71, 73).”
The molybdenum oxotransferases and related enzymes
Hille, R. (2013) · Dalton Transactions · doi:10.1039/c2dt32376a · Cited by 133 · cited 1×
“XOR is a part of a group of more than 50 different Mo-containing enzymes, the vast majority of which are bacterial enzymes (47).”
Velmurugan, S., Kapil, V., Ghosh, S. M., Davies, S., McKnight, A., Aboud, Z., Khambata, R. S., Webb, A. J., Poole, A., & Ahluwalia, A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.031 · Cited by 114 · cited 1×
“…ischemic CVD, the activity of XOR is increased both with increasing hypoxia and by increasing acidosis, and this enhanced activity is considered as underlying the beneficial effects of nitrite in I/R injury (56, 135) as well as the beneficial effects of nitrite on platelet function (118, 131) (Fig.”
Self-citationSafety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy Volunteers
Pluta, R. M., Oldfield, E. H., Bakhtian, K. D., Fathi, A. R., Smith, R. K., DeVroom, H. L., Nahavandi, M., Woo, S., Figg, W. D., & Lonser, R. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014504 · Cited by 112 · cited 1×
“Similarly, studies in healthy volunteers assessing the pharmacokinetics of nitrite infusion largely support the vascular studies in healthy volunteers, demonstrating that very large doses of nitrite (achieving circulating concentrations > 20 l M ) effect BP decreases (15, 103).”
The Reaction of Reduced Xanthine Dehydrogenase with Molecular Oxygen
Harris, C. M., & Massey, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8370 · Cited by 96 · cited 3×
“Importantly, studies with either purified enzyme or in situ XOR in endothelial cells demonstrate that superoxide generation, which occurs consequent to reperfusion, is not inhibited by allopurinol but is blocked by the FAD site inhibitor diphenyleneiodonium (DPI) (43, 110).”
Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells
Kelley, E. E., Hock, T., Khoo, N. K. H., Richardson, G. R., Johnson, K. K., Powell, P. C., Giles, G. I., Agarwal, A., Lancaster, J. R., & Tarpey, M. M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.008 · Cited by 93
Human xanthine oxidase converts nitrite ions into nitric oxide (NO)
Zhang, Z., Naughton, D. P., Blake, D. R., Benjamin, N., Stevens, C. R., Winyard, P. G., Symons, M. C. R., & Harrison, R. (1997) · Biochemical Society Transactions · doi:10.1042/bst025524s · Cited by 85
Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia
Poss, W. B., Huecksteadt, T. P., Panus, P. C., Freeman, B. A., & Hoidal, J. R. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.270.6.l941 · Cited by 79
Rouquette, M., Page, S., Bryant, R., Benboubetra, M., Stevens, C. R., Blake, D. R., Whish, W. D., Harrison, R., & Tosh, D. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00385-8 · Cited by 78
Classen, H. G., Stein-Hammer, C., & Thöni, H. (1990) · Journal of the American College of Nutrition · doi:10.1080/07315724.1990.10720407 · Cited by 59 · cited 1×
“Importantly, chronic oral administration of nitrite reduces BP without any evidence of tachyphylaxis in genetic, surgical, and salt-induced animal models of hypertension (8, 12, 13, 41, 88), although in general the doses of nitrite tested in these studies substantially exceed physiological levels.”
Wang (2013) · doi:10.1016/j.niox.2013.02.064 · Cited by 4
Cited by
Velmurugan, S., Gan, J. M., Rathod, K. S., Khambata, R. S., Ghosh, S. M., Hartley, A., Van Eijl, S., Sagi-Kiss, V., Chowdhury, T. A., Curtis, M., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.116244 · Cited by 284
Self-citationKapil, V., Khambata, R. S., Jones, D. A., Rathod, K., Primus, C., Massimo, G., Fukuto, J. M., & Ahluwalia, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019240 · Cited by 248
Self-citationAhluwalia, A., Gladwin, M., Coleman, G. D., Hord, N., Howard, G., Kim‐Shapiro, D. B., Lajous, M., Larsen, F. J., Lefer, D. J., McClure, L. A., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003402 · Cited by 92
“activity relates to nitrite reduction in health (globins) or nitrite reduction in disease (xanthine oxidoreductase).(26)”
BackgroundSelf-citationGee, L. C., & Ahluwalia, A. (2016) · Current Hypertension Reports · doi:10.1007/s11906-015-0623-4 · Cited by 80
Self-citation
Metadata
- Authors
- Khambata, R. S., Ghosh, S. M., & Ahluwalia, A.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2015-08
- Volume
- 23
- Issue
- 4
- Pages
- 340-353
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2105532508
- Cited by
- 31
- References
- 44
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.